See the work that we are doing to introduce new clinician-inspired tools to ophthalmology
?? Advancing Ocular Biopsy: Raising the Standard of Care ?? When it comes to ocular biopsy, precision and patient safety are paramount. The current method involves a 30-gauge needle and a 1-mL syringe, a procedure with its share of complexities and risks. Traditionally, a needle is inserted between the cornea and sclera to access the aqueous humor—a vital reservoir for confirming eye infections or tumors. The aqueous fluid, crucial for maintaining intraocular pressure, must be aspirated with utmost care. Any misstep can lead to complications, including iris bleeding, corneal scarring, vision loss, or even immediate cataract formation. At [Your Biotech Company], we're rewriting the rules. Our advanced engineering has led to a one-handed tool with a customized needle and collection chamber. It's a game-changer in improving patient safety and enhancing the reliability of testing. Join us in our mission to redefine the standard of care in ocular biopsy. Together, we're ensuring a brighter and safer future for ocular healthcare. #OcularBiopsy?#StandardOfCare?#MedicalInnovation?#PatientSafety?#Biotech?#OcularHealthcare